This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enriquez, F. J.
Right arrow Articles by Riggs, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enriquez, F. J.
Right arrow Articles by Riggs, M. W.

 Previous Article  |  Next Article 

Infection and Immunity, September 1998, p. 4469-4473, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Role of Immunoglobulin A Monoclonal Antibodies against P23 in Controlling Murine Cryptosporidium parvum Infection

F. Javier Enriquez,* and Michael W. Riggs

Department of Veterinary Science and Microbiology, University of Arizona, Tucson, Arizona 85721

Received 26 March 1998/Returned for modification 1 June 1998/Accepted 10 June 1998

Cryptosporidium parvum is an important diarrhea-causing protozoan parasite of immunocompetent and immunocompromised hosts. Immunoglobulin A (IgA) has been implicated in resistance to mucosal infections with bacteria, viruses, and parasites, but little is known about the role of IgA in the control of C. parvum infection. We assessed the role of IgA during C. parvum infection in neonatal mice. IgA-secreting hybridomas were developed by using Peyer's patch lymphocytes from BALB/c mice which had been orally inoculated with viable C. parvum oocysts. Six monoclonal antibodies (MAbs) were selected for further study based on indirect immunofluorescence assay reactivity with sporozoite and merozoite pellicles and the antigen (Ag) deposited on glass substrate by gliding sporozoites. Each MAb was secreted in dimeric form and recognized a 23-kDa sporozoite Ag in Western immunoblots. The Ag recognized comigrated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis with P23, a previously defined neutralization-sensitive zoite pellicle Ag. MAbs were evaluated for prophylactic or therapeutic efficacy against C. parvum, singly and in combinations, in neonatal BALB/c mice. A combination of two MAbs given prophylactically prior to and 12 h following oocyst challenge reduced the number of intestinal parasites scored histologically by 21.1% compared to the numbers in mice given an isotype-matched control MAb (P < 0.01). Individual MAbs given therapeutically in nine doses over a 96-h period following oocyst challenge increased efficacy against C. parvum infection. Four MAbs given therapeutically each reduced intestinal infection 34.4 to 42.2% compared to isotype-matched control MAb-treated mice (P < 0.05). One MAb reduced infection 63.3 and 72.7% in replicate experiments compared to isotype-matched control MAb-treated mice (P < 0.0001). We conclude that IgA MAbs directed to neutralization-sensitive P23 epitopes may have utility in passive immunization against murine C. parvum infection.


* Corresponding author. Mailing address: Department of Veterinary Science and Microbiology, Veterinary Science and Microbiology Building, Room 202, University of Arizona, Tucson, AZ 85721. Phone: (520) 621-4880. Fax: (520) 621-6366. E-mail: fje{at}u.arizona.edu.


Infection and Immunity, September 1998, p. 4469-4473, Vol. 66, No. 9
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Elm, C., Braathen, R., Bergmann, S., Frank, R., Vaerman, J.-P., Kaetzel, C. S., Chhatwal, G. S., Johansen, F.-E., Hammerschmidt, S. (2004). Ectodomains 3 and 4 of Human Polymeric Immunoglobulin Receptor (hpIgR) Mediate Invasion of Streptococcus pneumoniae into the Epithelium. J. Biol. Chem. 279: 6296-6304 [Abstract] [Full Text]  
  • Riggs, M. W., Schaefer, D. A., Kapil, S. J., Barley-Maloney, L., Perryman, L. E. (2002). Efficacy of Monoclonal Antibodies against Defined Antigens for Passive Immunotherapy of Chronic Gastrointestinal Cryptosporidiosis. Antimicrob. Agents Chemother. 46: 275-282 [Abstract] [Full Text]  
  • Dann, S. M., Okhuysen, P. C., Salameh, B. M., DuPont, H. L., Chappell, C. L. (2000). Fecal Antibodies to Cryptosporidium parvum in Healthy Volunteers. Infect. Immun. 68: 5068-5074 [Abstract] [Full Text]  
  • Strong, W. B., Gut, J., Nelson, R. G. (2000). Cloning and Sequence Analysis of a Highly Polymorphic Cryptosporidium parvum Gene Encoding a 60-Kilodalton Glycoprotein and Characterization of Its 15- and 45-Kilodalton Zoite Surface Antigen Products. Infect. Immun. 68: 4117-4134 [Abstract] [Full Text]  
  • Schaefer, D. A., Auerbach-Dixon, B. A., Riggs, M. W. (2000). Characterization and Formulation of Multiple Epitope-Specific Neutralizing Monoclonal Antibodies for Passive Immunization against Cryptosporidiosis. Infect. Immun. 68: 2608-2616 [Abstract] [Full Text]  
  • Jenkins, M. C., Trout, J., Murphy, C., Harp, J. A., Higgins, J., Wergin, W., Fayer, R. (1999). Cloning and Expression of a DNA Sequence Encoding a 41-Kilodalton Cryptosporidium parvum Oocyst Wall Protein. CVI 6: 912-920 [Abstract] [Full Text]  
  • Adjei, A. A., Jones, J. T., Riggs, M. W., Enriquez, F. J. (1999). Evidence of Thymus-Independent Local and Systemic Antibody Responses to Cryptosporidium parvum Infection in Nude Mice. Infect. Immun. 67: 3947-3951 [Abstract] [Full Text]  
  • Riggs, M. W., McNeil, M. R., Perryman, L. E., Stone, A. L., Scherman, M. S., O'Connor, R. M. (1999). Cryptosporidium parvum Sporozoite Pellicle Antigen Recognized by a Neutralizing Monoclonal Antibody Is a beta -Mannosylated Glycolipid. Infect. Immun. 67: 1317-1322 [Abstract] [Full Text]